This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Xin Miao
Introduction
Xin Miao is a notable inventor based in Blue Bell, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of malignancies. Her work is characterized by a focus on innovative compounds that target specific pathways in cancer treatment.
Latest Patents
Xin Miao holds a patent for "Inhibitors of Bruton's tyrosine kinase and methods of their use." This patent is directed towards the use of a compound of Formula (III) in the treatment of malignancies. The innovation represented by this patent is crucial for developing new therapeutic strategies in oncology.
Career Highlights
Xin Miao is currently employed at Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work at this leading pharmaceutical company allows her to collaborate with other experts in the field and contribute to groundbreaking medical advancements.
Collaborations
Xin Miao works alongside Ivo Cornelissen, who is also a key figure in her research endeavors. Their collaboration enhances the potential for innovative solutions in the pharmaceutical industry.
Conclusion
Xin Miao's contributions to the field of pharmaceuticals, particularly through her patent on Bruton's tyrosine kinase inhibitors, highlight her role as an influential inventor. Her work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile